SMi's Freeze-Drying for Pharmaceuticals and Biopharmaceuticals 2013

Share Article

SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals, with key talks from Medimmune, GSK Biologicals, National Institute for Biological Standards & Control and Roche on the best practices, novel discoveries and industry innovations that are essential to the development of a company’s lyophilisation process.

With a wealth of knowledge on Freeze-Drying, this conference will provide the perfect platform to bring together both buyers and suppliers as well as experienced Pharmaceuticals and Biopharmaceuticals professionals who will share their experiences and best practices.

SMi is pleased to confirm Yves Mayeresse, Director secondary operations, Manufacturing Center of Expertise, GlaxoSmithKline Vaccines as speaker who will address delegates on Risk Management approach and PAT tools to optimise lyophilisation robustness. His presentation will give participants a better understanding of the risk and guidelines for freeze-drying current technologies and future developments.

This event will act as a unique platform to hear from and discuss with key experts in the field on key topics that include:

  •     Scaling up techniques and optimisation case studies
  •     Lyophilisation monitoring, data analysis and risk reduction
  •     Non-conventional formulation techniques and approaches
  •     Moisture control and dried vaccine formulations
  •     Ice nucleation control and monitoring
  •     Product qualification and control
  •     PAT, TDLAS Raman Spectroscopy and optimal monitoring technologies and techniques
  •     Aseptic processes and process design

For more information visit
alternatively contact Jonathan Collins on +44 0 207 827 6734 or email on jcollins (at) smi-online (dot) co (dot) uk

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel
SMi Group Ltd
0207 827 6106
Email >
Follow us on
Visit website